本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Ventyx Biosciences, Inc.

1.18
+0.05004.42%
盘后1.180.00000.00%16:30 EDT
成交量:59.96万
成交额:70.45万
市值:8,393.35万
市盈率:-0.60
高:1.19
开:1.15
低:1.15
收:1.13
数据加载中...
2024/01/03

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/12/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/07

重要事件披露

Form 8-K - Current report
2023/11/22

重要事件披露

Form 8-K - Current report
2023/11/09

重要事件披露

Form 8-K - Current report
2023/11/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/07

重要事件披露

Form 8-K - Current report
2023/10/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/10/10

重要事件披露

Form 8-K - Current report
2023/10/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/10/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/10/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/11

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]